Solid Biosciences Inc. — Director's Dealing 2020

Jan 29, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Solid Biosciences Inc. (SLDB)
CIK: 0001707502
Period of Report: 2020-01-27

Reporting Person: HERSCHA LYNETTE (Chief Legal Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-01-27	Employee Stock Option (Right to Buy)	$3.47	A	65000	Acquired	2030-01-27	Common Stock (65000)	Direct
2020-01-27	Restricted Stock Unit	$0.00	A	32000	Acquired	2030-01-27	Common Stock (32000)	Direct

Footnotes

F1: This option was granted on January 27, 2020 and vests in four equal annual installments on the anniversary of the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events and the termination of the Reporting Person's employment under specified circumstances.

F2: The restricted stock units will vest in 2 installments. Fifty percent will vest six months after the grant date with the remaining fifty percent vesting on the first anniversary of the grant date and will vest automatically as to 100% of the unvested portion of such restricted stock unit grant upon specified change in control events and the termination of the Reporting Person's employment under specified circumstances.